Norvegija - norvegų - Statens legemiddelverk

orifarm as - lakosamid - tablett, filmdrasjert - 200 mg

Norvegija - norvegų - Statens legemiddelverk

orifarm as - lakosamid - tablett, filmdrasjert - 50 mg

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibakterielle midler for systemisk bruk, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.

Norvegija - norvegų - Statens legemiddelverk

2care4 aps - brivaracetam - tablett, filmdrasjert - 25 mg

Norvegija - norvegų - Statens legemiddelverk

2care4 aps - brivaracetam - tablett, filmdrasjert - 50 mg

Norvegija - norvegų - Statens legemiddelverk

2care4 aps - brivaracetam - tablett, filmdrasjert - 75 mg

Norvegija - norvegų - Statens legemiddelverk

2care4 aps - brivaracetam - tablett, filmdrasjert - 100 mg

Europos Sąjunga - norvegų - EMA (European Medicines Agency)

ucb pharma sa - brivaracetam - epilepsi - antiepileptics, - briviact er indisert som tilleggsbehandling ved behandling av delvis-utbruddet anfall med eller uten sekundær generalisering hos voksne og unge pasienter fra 16 år med epilepsi.

Norvegija - norvegų - Statens legemiddelverk

rph pharmaceuticals ab - fenytoin - tablett - 100 mg